Europe: HeiScreen Preps Liquid Biopsy Breast Cancer Test for Year-End Launch

Europe In-depth news and analysis on the European life science market

Optimization Studies for the Development of Highly Multiplexed Reference Materials in FFPE Format for Solid Tumor Profiling  This scientific poster video from SeraCare discusses the importance of highly multiplexed engineered reference materials in FFPE format. Download it from GenomeWeb’s library Recent European Headlines premium HeiScreen Preps Liquid Biopsy Breast Cancer Test for Year-End Launch Published on Mar 12, 2019 Ortho Clinical Diagnostics Multi-Test Technology Gets CE Mark Published on Mar 13, 2019 Grifols Acquires $1.9B Stake in Shanghai RAAS in Push for China Growth Published on Mar 08, 2019 Biocartis Inks Cancer CDx Deal With Bristol-Myers Squibb Published on Mar 12, 2019 Qiagen, Tecan Partner for TB Test Automation Published on Mar 08, 2019 Schistosomiasis Tests Being Developed by New FIND-Led Consortium Published on Mar 14, 2019 PGDx Liquid Biopsy Assay Gets CE Marking Published on Mar 14, 2019 Cutoff Values for Blood Test to Determine Heart Attack May Be Imperfect Published on Mar 14, 2019 BioChain Threatens Legal Action Against Epigenomics for Contract Termination Published on Mar 13, 2019 Advanced Biological Labs, Mayo Collaborate on Test for CMV Antiviral Resistance Published on Mar 12, 2019 Sona Nanotech, Olm Diagnostics Ink Agreement to Develop Infectious Disease POC Tests Published on Mar 12, 2019 Oxford Immunotec Q4 Revenues Grow 22 Percent on Quest Diagnostics Deal Published on Mar 12, 2019 Most Read Stories in Europe premium Molecular Macrolide Resistance Assay Shows Promise for Point-of-Care Use Published on Mar 14, 2019 premium Digital Pathology Startup Paige.AI Leveraging MSKCC Data, Machine Learning to Hasten Cancer Diagnosis Published on Mar 14, 2019 premium BRCA Screening Guidelines too Reliant on Family History, Stakeholders Tell USPSTF Published on Mar 14, 2019 Ovation Raises $5M in Series A Funding Published on Mar 14, 2019 Use of Molecular Identifiers and Targeted NGS to Enable Variant Detection Below 1% Allele Frequencies in Circulating Cell-Free DNA  This on-demand webinar from SeraCare highlights the power of MID technology in amplicon NGS library preparation to enable low frequency variant detection for cfDNA analysis. Download it from GenomeWeb’s library